Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 53 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
APOTHEEK T'KINDT from Bilzen-Hoeselt, company number BE0446212965, closed financial year 2025 with a result of € -10,683 after tax. For that financial year APOTHEEK T'KINDT recorded a gross margin of € 56,509 and equity of € -3,018. Compared with financial year 2024, the result moved from € -56,643 to € -10,683. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 3, 2026.
€ -3,018
▼ € 10,683 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -10,683
▲ 81 % less loss than in 2024
Profit after tax over the fiscal year.
€ 58,711
▲ € 47,145 vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -21,618.
People and assets in 2025
0.7
Average over the fiscal year, from the social balance sheet.
€ 32,588
▲ 2% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 309,420
▼ 16% vs 2024
€ 33,977 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 227,218
▲ 107% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 4,087
▼ 28% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 83,845 | € 163,118 | € 16,071 | € 56,509 | ▲ 252% |
| Profit after taxes | € 9,289 | € 86,771 | € -56,643 | € -10,683 | ▲ € 45,960 |
| Equity | € 64,237 | € 64,309 | € 7,666 | € -3,018 | ▼ € 10,683 |
| Total debts | € 613,021 | € 731,050 | € 503,504 | € 558,715 | ▲ 11% |
| Cash | € 57,749 | € 24,817 | € 11,565 | € 58,711 | ▲ € 47,145 |
| Land & buildings | € 367,440 | € 350,695 | € 334,965 | € 320,188 | ▼ 4% |
| Retained profit | € 45,637 | € 45,709 | € -10,934 | € -21,618 | ▼ € 10,683 |
| Dividend | € 9,000 | € 86,700 | € 0 | € 0 | |
| Bank debt | € 404,904 | € 424,116 | € 367,299 | € 309,420 | ▼ 16% |
| Balance sheet total | € 677,258 | € 795,359 | € 511,170 | € 555,697 | ▲ 9% |
| Employees (FTE) | 0.8 | 0.7 | 0.7 | 0.7 |
Key figures of APOTHEEK T'KINDT, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to APOTHEEK T'KINDT?
What happened at APOTHEEK T'KINDT in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 10,683. Source: NBB ↗
- Mees Management Apotheek BV became a director. NBB
- New establishment in Bilzen-Hoeselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 9,289 profit in 2022 to € 10,683 loss in 2025.
Paid € 3,695 in corporate taxes since 2022.
Best year ever: 2023, with € 86,771 profit.
Paid out € 95,700 in dividends to the owners in total.
A new publication or filing at APOTHEEK T'KINDT? We notify you, reason included.
Follow APOTHEEK T'KINDTDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of T'KINDT WIM, MEES MANAGEMENT APOTHEEK comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
APOTHEEK T'KINDTBehind APOTHEEK T'KINDT is Mees Management Apotheek BV. The shares are held by T'KINDT WIM (100%) and MEES MANAGEMENT APOTHEEK (100%).
Directors
According to the 2025 annual accounts
Director · represented by Mees Joris
Also active at: APOTHEEK MEES HASSELT, APOTHEEK MEES HAACHT CENTRUM, APOTHEEK VAN GORP, APOTHEEK MEES ZONHOVEN, APOTHEEK JANS, APOTHEEK MEES SCHULEN, APOTHEEK MEES HERK-DE-STAD, APOTHEEK MEES SINT-TRUIDEN +14 more
since 2025
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Schoonbeekstraat 21
3740 Bilzen-Hoeselt
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
AMAZON-02 - Amazon.com, Inc., US
DNS
AWS Route 53
Website info
Features
Security
Network
Details
- Company number
- 0446.212.965
- VAT number
- BE 0446.212.965
- Registered office
- Schoonbeekstraat 21, 3740 Bilzen-Hoeselt
- Names & denominations
- APOTHEEK T'KINDT
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 December 1991
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers